NLM Logo

DAC protocol 2 MeSH Supplementary Concept Data 2024


MeSH Supplementary
DAC protocol 2
Unique ID
C120198
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C120198
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Doxorubicin
Floxuridine
Frequency
1
Note
chemotherapy protocol consisting of doxifluridine (Floxuridine/aa), & other cpds; used in the treatment of advanced breast cancer
Source
Gan To Kagaku Ryoho 1999 May;26(6):775-9
Date of Entry
1999/10/01
Revision Date
2000/11/30
DAC protocol 2 Preferred
page delivered in 0.002s